Since solubility is the main constraint for oral bioavailability of silymarin, an attempt has been made to design tablet formulations of silymarin-HP-β-CD solid dispersion in order to improve oral bioavailability. Tablet formulations were prepared by direct compression technique using superdisintegrants such as crosscarmellose sodium, sodium starch glycolate and polyplasdone XL in different concentrations. Developed formulations were evaluated for various pharmaceutical characteristics viz. hardness, % friability, weight variation, drug content, disintegration time and in vitro dissolution profiles. Amongst different batches, formulations containing crosscarmellose sodium showed superior disintegration and dissolution profiles compared to other formulations. However all the formulations showed improved dissolution over marketed formulation reflecting vital role of HP-β-CD dispersion in promotion of silymarin oral bioavailability. Moreover, optimized formulation showed stability at varying temperature and relative humidity. www.ijpsonline.com
Together with the permeability, the solubility behavior of No.100, weighed and blended. The lubricated a drug is a key determinant of its oral bioavailability 1 .
formulations were compressed by direct compression Silymarin is a hepatoprotective and hepatogenerative technique using 12 mm concave faced punches. drug which is the standarised seed extract rich in flavanolignans. The main flavanolignans in silymarin are All prepared tablets and the marketed preparation were isomers silybin, silydianin and silychristin 2 . Silybin is the evaluated for drug content, friability, hardness, thickness main active component and basically silybin is silymarin 3 .
and weight variation 7
. Friability was determined using It is regarded as the single most important component in Roche friabilator 8 . Hardness was measured using Pfizer silymarin and has been subjected to numerous hardness tester. Thickness was measured using Vernier biochemical and pharmacological studies. The caliper. The drug content was estimated at 286 nm hepatoprotective activity of silymarin rests with strong (Shimadzu UV spectrophotometer 2401 PC, Japan). In antioxidant, free radical scavenging activity and vitro disintegration test was performed for tablets at 37±1 0 hepatogenerative activity is due to the ability of silybin to using the disintegration test apparatus (Tablet accelerate protein synthesis, and mitosis via activation of Disintegration Tester ED-2L (USP), Electrolab, Mumbai). DNA-dependent RNA-Polymerase which leads to
The study was conducted in triplicate. regeneration of hepatocytes 2 . However silybin is a water insoluble drug and shows poor dissolution characteristics 3 .
In vitro drug release study was done using USP II The water insolubility leads to poor bioavailability of the (paddle) apparatus with 900ml of dissolution medium drug with only 23-47% bioavailability and time taken to maintained at 37±2 o for 2 h at 75 rpm. Simulated gastric reach plasma concentration is about 1.3-4 hours 2, 4 . fluid (without pepsin) 9 was used as a dissolution medium. Silymarin has the solubility in simulated gastric fluid (pH Ten ml of sample was withdrawn after every 15 min and 1.2) and simulated intestinal fluid (pH 6.8) 0.209±0.65 mg/ml was replaced by equal volume of fresh medium and 0.148±0.88 mg/ml, respectively. maintained at 37±2 o . Samples were analyzed spectrophotometrically at 286 nm and cumulative % drug In light of above facts, solid dispersions of silymarin were release was calculated. The study was performed in prepared, with β-CD or HP-β-CD in various ratios (1:1, triplicate. Optimized formulation A3 was tested for stability 1:2, and 1:3 w/w) of drug to polymer, by kneading method at ambient temperature (R.T.) and 45±2 o at 75%±5% R.H. using hydroalcoholic solvent (1:1). Among these ratios, for a span of three months. drug to HP-β-CD (1:3 w/w) ratio showed best dissolution characteristics and thus, in the present study conventional
The study of physical parameters of the formulations tablets of silymarin-HP-β-CD (1:3) dispersion were revealed that all the tablets were acceptable in regard to prepared by using superdisintegrants in various silymarin content, weight variation, hardness and concentrations 5, 6 . thickness (Table 2) . Among the three disintegrants used, Crosscarmellose sodium demonstrated best disintegration Tablets of silymarin-HP-β-CD solid dispersions were power as compared to other two disintegrants. This might prepared by using different disintegrants in 4, 6 and 8%.
be again attributed to their mechanism, which may Microcrystalline cellulose was used as a diluent and comprise capillary action with a secondary burst effect. magnesium stearate (2%) was used as a lubricant. The
The result also showed decrease in disintegration time as compositions of various formulations are as shown in the concentration of superdisintegrants increases from 4% Table 1 . All the ingredients were passed through sieve to 8%. This can be correlated to tablet matrix pore size distribution created by the use of superdisintegrants.
